Company <> TA Flashcards
(6 cards)
1
Q
Bluebird Bio
A
Gene therapy
2
Q
CRISPR
A
Gene editing
3
Q
Voyager
A
Gene therapy (AAV, neuro)
4
Q
Prevail
A
Gene therapy (AAV, neuro); acquired by Lilly for $1.0bn
5
Q
Nightstar
A
Gene therapy (rare ophtho); acquired by Biogen for $880mm in 2019
6
Q
Biogen
A
- neuro, ophtho, pain, immu (lupus, MS)
- top products: spinraza (SMA), tecfidera (rMS), tysabri (rMS)
